東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Survival Outcomes in T3 Laryngeal Ca...

Wang, Vickie Jiaying.

FindBook

Google Book

Amazon

博客來

Survival Outcomes in T3 Laryngeal Cancer Based on Staging Features at Diagnosis.

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Survival Outcomes in T3 Laryngeal Cancer Based on Staging Features at Diagnosis./
作者:	Wang, Vickie Jiaying.
出版者:	Ann Arbor : ProQuest Dissertations & Theses, : 2024,
面頁冊數:	47 p.
附註:	Source: Dissertations Abstracts International, Volume: 85-11, Section: B.
Contained By:	Dissertations Abstracts International85-11B.
標題:	Oncology. -
電子資源:	https://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=31143975
ISBN:	9798382321196

Survival Outcomes in T3 Laryngeal Cancer Based on Staging Features at Diagnosis.
Wang, Vickie Jiaying.

Survival Outcomes in T3 Laryngeal Cancer Based on Staging Features at Diagnosis. - Ann Arbor : ProQuest Dissertations & Theses, 2024 - 47 p.

Source: Dissertations Abstracts International, Volume: 85-11, Section: B.

Thesis (M.D.)--Yale University, 2024.

Stage T3 laryngeal cancer is defined by the presence of vocal cord fixation and/or invasion into any of the following: pre-epiglottic space, paraglottic fat, post-cricoid space, or inner cortex of the thyroid cartilage. These cancers are usually treated with chemoradiation rather than upfront total laryngectomy. To our knowledge, no studies have directly compared differences in survival among the varied features within the T3 staging category. This study aims to determine how the presence of each of these staging features impacts overall and laryngectomy-free survival.Patients with clinically-diagnosed T3 laryngeal squamous cell carcinoma seen at our institution between 2010-2021 were retrospectively identified. Medical record information was collected for patient demographics, tumor characteristics, treatment course, and survival. Records were reviewed with head and neck surgeons and neuroradiologists when there was uncertainty. Patients were excluded if tumor and/or treatment information was incomplete, if metastatic disease was present at diagnosis, or if they were treated with upfront laryngectomy.For statistical analysis, the cohort was stratified in two ways: by number of T3 staging features and by type of feature. Pre-epiglottic, paraglottic, and post-cricoid space invasion{A0}were grouped together as "soft tissue invasion". The primary outcome was overall survival (OS), and the secondary outcome was laryngectomy-free survival (LFS, the proportion of patients alive without laryngectomy, out of all alive patients at a certain timepoint).102 patients met inclusion criteria for analysis, who were 79.4% male (81) and were diagnosed at a mean age of 65.3 {phono}{lstrok} 11.4 years. 68.4% of patients (67) presented with a single T3 staging feature. 48.0% of patients (49) had vocal cord fixation (either alone or in combination with other features), 63.7% (65) had soft tissue invasion, and 10.8% (11) had thyroid cartilage involvement. OS was 68.6% at 2 years and 47.9% at 5 years. LFS was 74.2% at 2 years and 72.1% at 5 years.On Kaplan-Meier survival analysis comparing different staging features, thyroid cartilage involvement had a significant impact on OS (p<0.001). Cox proportional hazard regression analysis showed that older age at diagnosis (p<0.001), higher overall cancer stage (p=0.003), and thyroid cartilage involvement (p<0.001) all had significant impacts on OS. There were no demographic or clinical features which had a significant impact on LFS, i.e. features of patients who were more likely to receive salvage laryngectomy. Our results suggest that overall survival may be worse for patients with thyroid cartilage invasion. The difficulty of radiologically determining the degree of thyroid cartilage invasion, which distinguishes stage T3 from stage T4 laryngeal cancer, may contribute to this finding. However, the possibility that any thyroid cartilage invasion portends worse survival cannot be excluded. In order to optimize survival for patients with T3 laryngeal cancer, our findings should be further validated with larger datasets and prospective studies to assess the need for potential changes in tumor staging or treatment guidelines.

ISBN: 9798382321196Subjects--Topical Terms:

751006
Oncology.
Subjects--Index Terms:

Cancer survival

Survival Outcomes in T3 Laryngeal Cancer Based on Staging Features at Diagnosis.
LDR:04328nmm a2200385 4500 001 2404404
005 20241209114624.5
006 m o d
007 cr#unu||||||||
008 251215s2024 ||||||||||||||||| ||eng d
020 $a 9798382321196
035 $a (MiAaPQ)AAI31143975
035 $a AAI31143975
040 $a MiAaPQ $c MiAaPQ
100 1 $a Wang, Vickie Jiaying. $3 3774720
245 1 0 $a Survival Outcomes in T3 Laryngeal Cancer Based on Staging Features at Diagnosis.
260 1 $a Ann Arbor : $b ProQuest Dissertations & Theses, $c 2024
300 $a 47 p.
500 $a Source: Dissertations Abstracts International, Volume: 85-11, Section: B.
500 $a Advisor: Mehra, Saral.
502 $a Thesis (M.D.)--Yale University, 2024.
520 $a Stage T3 laryngeal cancer is defined by the presence of vocal cord fixation and/or invasion into any of the following: pre-epiglottic space, paraglottic fat, post-cricoid space, or inner cortex of the thyroid cartilage. These cancers are usually treated with chemoradiation rather than upfront total laryngectomy. To our knowledge, no studies have directly compared differences in survival among the varied features within the T3 staging category. This study aims to determine how the presence of each of these staging features impacts overall and laryngectomy-free survival.Patients with clinically-diagnosed T3 laryngeal squamous cell carcinoma seen at our institution between 2010-2021 were retrospectively identified. Medical record information was collected for patient demographics, tumor characteristics, treatment course, and survival. Records were reviewed with head and neck surgeons and neuroradiologists when there was uncertainty. Patients were excluded if tumor and/or treatment information was incomplete, if metastatic disease was present at diagnosis, or if they were treated with upfront laryngectomy.For statistical analysis, the cohort was stratified in two ways: by number of T3 staging features and by type of feature. Pre-epiglottic, paraglottic, and post-cricoid space invasion{A0}were grouped together as "soft tissue invasion". The primary outcome was overall survival (OS), and the secondary outcome was laryngectomy-free survival (LFS, the proportion of patients alive without laryngectomy, out of all alive patients at a certain timepoint).102 patients met inclusion criteria for analysis, who were 79.4% male (81) and were diagnosed at a mean age of 65.3 {phono}{lstrok} 11.4 years. 68.4% of patients (67) presented with a single T3 staging feature. 48.0% of patients (49) had vocal cord fixation (either alone or in combination with other features), 63.7% (65) had soft tissue invasion, and 10.8% (11) had thyroid cartilage involvement. OS was 68.6% at 2 years and 47.9% at 5 years. LFS was 74.2% at 2 years and 72.1% at 5 years.On Kaplan-Meier survival analysis comparing different staging features, thyroid cartilage involvement had a significant impact on OS (p<0.001). Cox proportional hazard regression analysis showed that older age at diagnosis (p<0.001), higher overall cancer stage (p=0.003), and thyroid cartilage involvement (p<0.001) all had significant impacts on OS. There were no demographic or clinical features which had a significant impact on LFS, i.e. features of patients who were more likely to receive salvage laryngectomy. Our results suggest that overall survival may be worse for patients with thyroid cartilage invasion. The difficulty of radiologically determining the degree of thyroid cartilage invasion, which distinguishes stage T3 from stage T4 laryngeal cancer, may contribute to this finding. However, the possibility that any thyroid cartilage invasion portends worse survival cannot be excluded. In order to optimize survival for patients with T3 laryngeal cancer, our findings should be further validated with larger datasets and prospective studies to assess the need for potential changes in tumor staging or treatment guidelines.
590 $a School code: 0265.
650 4 $a Oncology. $3 751006
650 4 $a Public health. $3 534748
650 4 $a Cellular biology. $3 3172791
653 $a Cancer survival
653 $a Neck cancer
653 $a Laryngeal cancer
653 $a Laryngectomy
653 $a Head cancer
690 $a 0992
690 $a 0379
690 $a 0573
710 2 $a Yale University. $b Yale School of Medicine. $3 3422308
773 0 $t Dissertations Abstracts International $g 85-11B.
790 $a 0265
791 $a M.D.
792 $a 2024
793 $a English
856 4 0 $u https://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=31143975